Wszystkie pola: omega-3 polyunsaturated fatty acid - Katalog OPAC zbiorów

Skocz do pozycji: 1.

Tytuł:: Anti-microinflammatory lipid signals generated from dietary N-3 fatty acids via cyclooxygenase-2 and transcellular processing: a novel mechanism for NSAID and N-3 PUFA therapeutic actions
Autorzy:: Serhan, C.N.
Clish, C.B.
Brannon, J.
Colgan, S.P.
Gronert, K.
Chiang, N.
Powiązania:: https://bibliotekanauki.pl/articles/69435.pdf
Data publikacji:: 2000
Wydawca:: Polskie Towarzystwo Fizjologiczne
Tematy:: omega-3 polyunsaturated fatty acid
transcellular processing
mouse
mice
prostaglandin
lipid
therapy
eicosanoid
cyclooxygenase-2
aspirin
fatty acid
leucocyte
Źródło:: Journal of Physiology and Pharmacology; 2000, 51, 4,1
0867-5910
Pojawia się w:: Journal of Physiology and Pharmacology
Dostawca treści:: Biblioteka Nauki

Artykuł

Zmień widok

na półce

Skocz do pozycji: 2.

Tytuł:: Microemulsions as Carriers of Omega-3 Polyunsaturated Fatty Acids
Mikroemulsje jako nośniki kwasów tłuszczowych omega-3
Autorzy:: GÓRSKA, Anna
KRUPA, Anna
Powiązania:: https://bibliotekanauki.pl/articles/1033822.pdf
Data publikacji:: 2013
Wydawca:: Zakład Opieki Zdrowotnej Ośrodek Umea Shinoda-Kuracejo
Tematy:: docosahexaenoic acid (DHA)
eicosapentaenoic acid (EPA)
functional foods
microemulsions
microencapsulation
α-linolenic acid
Opis:: Design of novel foodstuffs rich in natural bioactive substances is one of the main research field in the food industry. There are many clinical reports on beneficial effects of either docosahexaenoic acid (DHA) or eicosapentaenoic acid (EPA) on health. In general n-3 polyunsaturated fatty acids (n-3 PUFAs) are significant structural components of cell membranes. Since DHA and EPA represent exogenous fatty acids, their level in the human body depends on the dietary intake. Therefore there is a need to enrich food by bioactive compounds. It has been shown that the application of polyunsaturated fatty acids such as α-linolenic acid in traditional foodstuffs permits to obtain a kind of functional food that can be used to improve both health and skin condition. However low stability of natural bioactive components limits their application in food, especially on an industrial scale. Due to this fact efforts are made to prepare new functional food formula containing n-3 PUFAs in a stable form. Microencapsulation process is a well known attempt to prevent their oxidation. Preparation of food-grade microemulsions containing polyunsaturated fatty acids to improve the stability and to ensure pleasant sensory properties of food is discussed in the present study.
Źródło:: Medicina Internacia Revuo; 2013, 25, 101; 211- 219
0465-5435
Pojawia się w:: Medicina Internacia Revuo
Dostawca treści:: Biblioteka Nauki

Artykuł

Zmień widok

na półce

Skocz do pozycji: 3.

Tytuł:: Therapeutic advantages of omega-3 fatty acid supplementation in patients with schizophrenia – a systematic review
Autorzy:: Vityala, Srilaxmi
Priya Kanteti, Krishna
Vityala, Yethindra
Tagaev, Tugolbai
Damineni, Ujwala
Powiązania:: https://bibliotekanauki.pl/articles/40499950.pdf
Data publikacji:: 2024-03-30
Wydawca:: Uniwersytet Rzeszowski. Wydawnictwo Uniwersytetu Rzeszowskiego
Tematy:: docosahexaenoic acid
eicosapentaenoic acid
omega-3 polyunsaturated fatty acids
schizophrenia
supplementation
Opis:: Introduction and aim. In patients with schizophrenia, omega-3 (n-3) polyunsaturated fatty acids (PUFAs) treatment was found to ameliorate the cardiovascular, metabolic, and inflammatory problems caused by antipsychotic medication and even reduce the need for medication by 20%. In this study, we evaluated the potential therapeutic effects of n-3 PUFA supplementation in patients with schizophrenia. Material and methods. The PRISMA guidelines were followed in conducting this systematic review. The Embase, MEDLINE, Web of Science, and Google Scholar databases were searched electronically. The first search yielded 50 papers in total. Subsequently, 43 publications that did not meet our eligibility requirements were removed, and seven articles were selected. Analysis of the literature. The analysis showed that n-3 PUFA supplementation and the placebo group both decreased their psychotic (PANSS and GAF scales) and Calgary Depression Scale symptomatology and boosted their functional ability (GAF) when used as an adjuvant to antipsychotic medication. When administered as a monotherapy with a metabolic antioxidant, n-3 PUFA supplementation proved beneficial for treating schizophrenia. In patients with schizophrenia, n-3 PUFAs have therapeutic benefits as adjuvant treatments to medications, although not for different variables or patient groups. Conclusion. In many studies, patients with chronic schizophrenia who received n-3 PUFA supplementation showed no improvement in their clinical condition.
Źródło:: European Journal of Clinical and Experimental Medicine; 2024, 22, 1; 172-178
2544-2406
2544-1361
Pojawia się w:: European Journal of Clinical and Experimental Medicine
Dostawca treści:: Biblioteka Nauki

Artykuł

Zmień widok

na półce

Informacja

Wyszukujesz frazę "omega-3 polyunsaturated fatty acid" wg kryterium: Wszystkie pola

Źródło danych

Dostawca treści

Kolekcja

Rok wydania

Wydawca

Temat

Autor

Typ dokumentu

Język